Common breast cancer susceptibility loci are associated with triple-negative breast cancer.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Cancer Research

• Publication date

  2011-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-11-1266PMID 21844186PMCID PMC3327299
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A genome-wide association study identifies alleles in FGFR 2 associated with risk of sporadic postmenopausal breast cancer

  2012cited by this paper
• Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wide association study.

  2011cited by this paper
• Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.

  2011influential reference
• Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study

  2010cited by this paper
• Genome-wide association study identifies five new breast cancer susceptibility loci

  2010cited by this paper
• Ancestry-Shift Refinement Mapping of the C6orf97-ESR1 Breast Cancer Susceptibility Locus

  2010cited by this paper
• Triple-negative breast cancer.

  2010cited by this paper
• Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

  2010cited by this paper
• A genome-wide association scan on estrogen receptor-negative breast cancer

  2010cited by this paper
• Progesterone induces adult mammary stem cell expansion

  2010cited by this paper
• Control of mammary stem cell function by steroid hormone signalling

  2010cited by this paper
• A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population

  2010influential reference
• Common variants at 19p13 are associated with susceptibility to ovarian cancer

  2010cited by this paper
• NordicDB: a Nordic pool and portal for genome-wide control data

  2010cited by this paper
• Genome-wide association study identifies a novel breast cancer susceptibility locus at 6q25.1

  2009cited by this paper
• NCCN Task Force Report: Estrogen Receptor and Progesterone Receptor Testing in Breast Cancer by Immunohistochemistry.

  2009cited by this paper
• Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2

  2009cited by this paper
• A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1)

  2009cited by this paper
• MERIT40 facilitates BRCA1 localization and DNA damage repair.

  2009cited by this paper
• NBA1, a new player in the Brca1 A complex, is required for DNA damage resistance and checkpoint control.

  2009cited by this paper
• MERIT40 controls BRCA1-Rap80 complex integrity and recruitment to DNA double-strand breaks.

  2009cited by this paper
• Epidemiology of basal-like breast cancer

  2008cited by this paper
• Triple-negative breast cancer.

  2008influential reference
• Triple-Negative Breast Cancer: Risk Factors to Potential Targets

  2008cited by this paper
• Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer

  2008cited by this paper
• Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

  2008cited by this paper
• Genetic Susceptibility Loci for Breast Cancer by Estrogen Receptor Status

  2008cited by this paper
• Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

  2008cited by this paper
• What is triple-negative breast cancer?

  2008cited by this paper
• Current issues in ER and HER2 testing by IHC in breast cancer

  2008cited by this paper
• Genome-wide association study identifies novel breast cancer susceptibility loci

  2008cited by this paper
• Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype

  2007cited by this paper
• A common coding variant in CASP8 is associated with breast cancer risk

  2007cited by this paper
• Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor–positive breast cancer

  2007cited by this paper
• A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer

  2007cited by this paper
• Genome-wide association study identifies novel breast cancer susceptibility loci

  2007cited by this paper
• Differences in Risk Factors for Breast Cancer Molecular Subtypes in a Population-Based Study

  2007cited by this paper
• Establishing a Cancer Center Data Bank and Biorepository for Multidisciplinary Research

  2006cited by this paper
• Cancer Epidemiol Biomarkers Prev

  2004cited by this paper
• TOX defines a conserved subfamily of HMG-box proteins

  2003cited by this paper
• Measuring inconsistency in meta-analyses

  2003cited by this paper
• Complex Formation by the Human Rad51B and Rad51C DNA Repair Proteins and Their Activities in Vitro *

  2002cited by this paper
• Meta-analysis in clinical trials.

  1986cited by this paper
• Prospective study of Outcomes in Sporadic versus Hereditary breast cancer (POSH) Steering

  year unknowncited by this paper

• Race-related host and microbe transcriptomic signatures in triple-negative breast cancer

  2025cites this paper
• Joint impacts of genetic and non-genetic risk scores on risks of different subtypes of breast cancer among Chinese females

  2025cites this paper
• Update Mammakarzinom 2024 Teil 2 – Patientinnen mit Frühstadien des Mammakarzinoms

  2024cites this paper
• Cis- and trans-eQTL TWASs of breast and ovarian cancer identify more than 100 susceptibility genes in the BCAC and OCAC consortia.

  2024cites this paper
• Update Breast Cancer 2024 Part 2 – Patients with Early Stage Breast Cancer

  2024cites this paper
• Young Women with Breast Cancer: The Current Role of Precision Oncology

  2023cites this paper
• Cis- and trans-eQTL TWAS of breast and ovarian cancer identify more than 100 risk associated genes in the BCAC and OCAC consortia

  2023cites this paper
• Unique ESR1 and ESR2 estrogen receptor gene variants associated with altered risk of triple-negative breast cancer: a case-control study.

  2022cites this paper
• Update Mammakarzinom 2022 Teil 1 – Brustkrebs in frühen Krankheitsstadien

  2022cites this paper
• Update Breast Cancer 2022 Part 1 – Early Stage Breast Cancer

  2022cites this paper
• Update Breast Cancer 2022 Part 3 – Early-Stage Breast Cancer

  2022cites this paper
• Molecular Subtyping of Cancer Based on Robust Graph Neural Network and Multi-Omics Data Integration

  2022cites this paper
• Update Mammakarzinom 2022 Teil 3 – Brustkrebs in frühen Krankheitsstadien

  2022cites this paper
• Identification and Mechanism of the PD-1/PD-L1 Genomic Signature SORL1 as Protective Factor in Bladder Cancer

  2021cites this paper
• Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment

  2021cites this paper
• ANKLE1 as New Hotspot Mutation for Breast Cancer in Indian Population and Has a Role in DNA Damage and Repair in Mammalian Cells

  2021cites this paper
• A predictor of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer patients with the DNA repair genes

  2021cites this paper
• A Possible Link of Genetic Variations in ER/IGF1R Pathway and Risk of Melanoma

  2020cites this paper
• ANKLE1 N6‐Methyladenosine‐related variant is associated with colorectal cancer risk by maintaining the genomic stability

  2020cites this paper
• Critical Analysis of Genome-Wide Association Studies: Triple Negative Breast Cancer Quae Exempli Causa

  2020influential citation
• Impact of Gene–Environment Interactions on Cancer Development

  2020cites this paper
• Update Breast Cancer 2019 Part 4 – Diagnostic and Therapeutic Challenges of New, Personalised Therapies for Patients with Early Breast Cancer

  2019cites this paper
• Deconvolution of the Genomic and Epigenomic Interaction Landscape of Triple-Negative Breast Cancer

  2019cites this paper
• An Integrative Genomics Approach for Associating Genetic Susceptibility with the Tumor Immune Microenvironment in Triple Negative Breast Cancer.

  2019cites this paper
• A Review of the Hereditary Component of Triple Negative Breast Cancer: High- and Moderate-Penetrance Breast Cancer Genes, Low-Penetrance Loci, and the Role of Nontraditional Genetic Elements

  2019cites this paper
• Update Mammakarzinom 2019 Teil 4 – diagnostische und therapeutische Herausforderungen neuer personalisierter Therapien für Patientinnen mit frühem Mammakarzinom

  2019cites this paper
• Update Mammakarzinom 2019 Teil 1 – Implementierung der Ergebnisse neuer Studienkonzepte beim frühen Mammakarzinom in die klinische Praxis

  2019cites this paper
• Germline Variants Impact Somatic Events during Tumorigenesis.

  2019cites this paper
• Update Breast Cancer 2019 Part 1 – Implementation of Study Results of Novel Study Designs in Clinical Practice in Patients with Early Breast Cancer

  2019cites this paper
• Update Mammakarzinom 2019 Teil 3 – aktuelle Entwicklungen bei der kurativen Behandlung von Mammakarzinom-Patientinnen: Eine Übersicht und Bewertung durch ein internationales Expertenpanel

  2019cites this paper
• Update Breast Cancer 2019 Part 3 – Current Developments in Early Breast Cancer: Review and Critical Assessment by an International Expert Panel

  2019cites this paper
• The 6q25.1 rs2046210 polymorphism is associated with an elevated susceptibility to breast cancer: A meta‐analysis of 261,703 subjects

  2019cites this paper
• Evaluation of significant genome-wide association studies risk — SNPs in young breast cancer patients

  2019cites this paper
• Polygenic Risk Scores in Breast Cancer

  2019cites this paper
• Update Mammakarzinom 2019 Teil 1 – Implementierung der Ergebnisse neuer Studienkonzepte beim frühen Mammakarzinom in die klinische Praxis

  2019cites this paper
• Update Mammakarzinom 2019 Teil 3 – aktuelle Entwicklungen bei der kurativen Behandlung von Mammakarzinompatientinnen: eine Übersicht und Bewertung durch ein internationales Expertenpanel

  2019cites this paper
• Translational highlights in breast cancer research and treatment: recent developments with clinical impact

  2019cites this paper
• Update Mammakarzinom 2017 – Etablierung neuer zielgerichteter Therapien

  2018cites this paper
• Common Genetic Variation and Breast Cancer Risk—Past, Present, and Future

  2018cites this paper
• Evaluation of three polygenic risk score models for the prediction of breast cancer risk in Singapore Chinese

  2018cites this paper
• Association of Cell-Free DNA Tumor Fraction and Somatic Copy Number Alterations With Survival in Metastatic Triple-Negative Breast Cancer.

  2018cites this paper
• Update Breast Cancer 2018 (Part 4) – Genomics, Individualized Medicine and Immune Therapies – in the Middle of a New Era: Treatment Strategies for Advanced Breast Cancer

  2018cites this paper
• Adolescent and Young Adult Cancer Biology.

  2018cites this paper
• The Biology of AYA Cancers

  2017cites this paper
• Evaluation of the association between common genetic variants and breast cancer risk

  2017cites this paper
• A qualitative study on Singaporean women’s views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies

  2017cites this paper
• ER and PR Positive, or Her2 Negative Tumor of rs2363956 and rs3803662 GWAS in Breast Cancer

  2017cites this paper
• Predicting Triple-Negative Breast Cancer Subtype Using Multiple Single Nucleotide Polymorphisms for Breast Cancer Risk and Several Variable Selection Methods

  2017cites this paper
• Common variants at 12 p 11 , 12 q 24 , 9 p 21 , 9 q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers

  2017cites this paper
• Identification of breast cancer associated variants that modulate transcription factor binding

  2017cites this paper
• Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers

  2017cites this paper
• Update Breast Cancer 2017 – Implementation of Novel Therapies

  2017cites this paper
• Breast cancer genetics in young women: What do we know?

  2017cites this paper
• Evaluation of a newly discovered breast cancer susceptibility locus at 6q25.1 in Iranian Azari-Turkish women

  2016cites this paper
• Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma

  2016cites this paper
• Previous GWAS hits in relation to young-onset breast cancer

  2016cites this paper
• The GIY-YIG Type Endonuclease Ankyrin Repeat and LEM Domain-Containing Protein 1 (ANKLE1) Is Dispensable for Mouse Hematopoiesis

  2016cites this paper
• Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

  2016influential citation
• Relationship between five GWAS-identified single nucleotide polymorphisms and female breast cancer in the Chinese Han population

  2016cites this paper
• Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

  2016cites this paper
• An overview of triple-negative breast cancer

  2016cites this paper
• Nucleo-cytoplasmic shuttling of the endonuclease ankyrin repeats and LEM domain-containing protein 1 (Ankle1) is mediated by canonical nuclear export- and nuclear import signals

  2016cites this paper
• Association of a single nucleotide polymorphism at 6q25.1, rs2046210 with breast cancer risk among Vietnamese population

  2016influential citation
• An exome-wide analysis of low frequency and rare variants in relation to risk of breast cancer in African American Women: the AMBER Consortium.

  2016cites this paper
• Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes

  2016cites this paper
• Genetic variants in the HER2 gene: Influence on HER2 overexpression and loss of heterozygosity in breast cancer.

  2016cites this paper
• Genetic evaluation of BRCA1-A complex genes with triple-negative breast cancer susceptibility in Chinese women

  2016cites this paper
• GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients

  2016cites this paper
• The breast cancer susceptibility-related polymorphisms at the TOX3/LOC643714 locus associated with lung cancer risk in a Han Chinese population

  2016influential citation
• TOX3 is expressed in mammary ER+ epithelial cells and regulates ER target genes in luminal breast cancer

  2015cites this paper
• Association of three SNPs in TOX3 and breast cancer risk: Evidence from 97275 cases and 128686 controls

  2015cites this paper
• Prognostic and Predictive Factors in Metastatic Breast Cancer

  2015cites this paper
• Breast Cancer Update 2014 - Focus on the Patient and the Tumour.

  2015cites this paper
• Hormone Therapy and its Effect on the Prognosis in Breast Cancer Patients

  2015cites this paper
• Evaluating 17 breast cancer susceptibility loci in the Nashville breast health study

  2015cites this paper
• Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network.

  2015cites this paper
• The possible role of EZH2 and DNMT1 polymorphisms in sporadic triple-negative breast carcinoma in southern Chinese females

  2015cites this paper
• Mammakarzinom Update 2014 – Die Patientin und der Tumor im Mittelpunkt

  2015cites this paper
• Mammakarzinom Update 2014 – Die Patientin und der Tumor im Mittelpunkt

  2015cites this paper
• Identification of shared and unique susceptibility pathways among cancers of the lung, breast, and prostate from genome-wide association studies and tissue-specific protein interactions.

  2015cites this paper
• Identi fi cation of shared and unique susceptibility pathways among cancers of the lung , breast , and prostate from genome-wide association studies and tissue-speci fi c protein interactions

  2015cites this paper
• Lamina-associated polypeptide (LAP)2α and other LEM proteins in cancer biology.

  2014cites this paper
• Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

  2014cites this paper
• RAD51B Activity and Cell Cycle Regulation in Response to DNA Damage in Breast Cancer Cell Lines

  2014cites this paper
• Prognostic information of a previously diagnosed sister is an independent prognosticator for a newly diagnosed sister with breast cancer.

  2014cites this paper
• Genetic variation in estrogen and progesterone pathway genes and breast cancer risk: an exploration of tumor subtype-specific effects

  2014cites this paper
• 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

  2014cites this paper
• Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.

  2014influential citation
• Cancer Biology and the Nuclear Envelope

  2014cites this paper
• Genome-wide association studies and the clinic: a focus on breast cancer.

  2014cites this paper
• Genetic Susceptibility to Triple‐Negative Breast Cancers

  2014cites this paper
• Novel Integrative Genomics Approach for Associating GWAS Information with Intrinsic Subtypes of Breast Cancer

  2013cites this paper
• Breast Cancer Genomics: From Portraits to Landscapes

  2013cites this paper
• Breast Cancer Risk - From Genetics to Molecular Understanding of Pathogenesis Mammakarzinomrisiko - Genetik und molekulare Mechanismen der Pathogenese

  2013cites this paper
• Association between a novel polymorphism (rs2046210) of the 6q25.1 locus and breast cancer risk

  2013cites this paper
• Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

  2013cites this paper
• University of Groningen Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk Couch,

  2013cites this paper
• Association of low-penetrance alleles with male breast cancer risk and clinicopathological characteristics: results from a multicenter study in Italy

  2013cites this paper
• Single nucleotide polymorphism 6q25.1 rs2046210 and increased risk of breast cancer

  2013cites this paper
• Metabotropic Glutamate Receptor 1 Expression and Its Polymorphic Variants Associate with Breast Cancer Phenotypes

  2013cites this paper